Triple-negative breast cancer (TNBC), which is characterized by of the absence of expression of HER2, ER, and progesterone receptor (PR), is the most aggressive subtype and does not benefit from hormonal or targeted therapies [3]. The gene discussed is PGR; the disease is triple-negative breast carcinoma.